FIRST AMENDMENT TO PATENT AND TECHNOLOGYPatent and Technology License and Purchase Option Agreement • March 31st, 2017 • Q BioMed Inc. • Pharmaceutical preparations
Contract Type FiledMarch 31st, 2017 Company IndustryTHIS AGREEMENT (the “Amended Agreement”), dated September 6, 2016, amends the Patent and Technology License and Purchase Option Agreement (the “License Agreement”) entered into on May 30, 2016 by and between (i) Q BioMed Inc. (“Q Bio”) and (ii) Bio-Nucleonics Inc. (“BNI”) (together, the “Parties”)
AMENDMENT TO PATENT AND TECHNOLOGY LICENSE AND PURCHASE OPTION AGREEMENTPatent and Technology License and Purchase Option Agreement • February 28th, 2022 • Q BioMed Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 28th, 2022 Company IndustryTHIS AGREEMENT (the “Amended Agreement”), dated March 26, 2019, amends the Patent and Technology License and Purchase Option Agreement (the “License Agreement”) entered into on October 29, 2015 by and between (i) Q BioMed Inc. (“Q Bio”) and (ii) Mannin Research Inc. (“Mannin”) (together, the “Parties”).
PATENT AND TECHNOLOGY LICENSE AND PURCHASE OPTION AGREEMENTPatent and Technology License and Purchase Option Agreement • October 17th, 2016 • Q BioMed Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 17th, 2016 Company Industry JurisdictionThis Patent and Technology License and Purchase Option Agreement is entered into on June 20, 2016 (“Signing Date”) by and between (i) Q BioMed Inc. (“Q Bio”) and (ii) Bio-Nucleonics Inc. (“BNI”): BNI and Q Bio are hereinafter also referred to individually as a “Party” and collectively as the “Parties.”
PATENT AND TECHNOLOGY LICENSE AND PURCHASE OPTION AGREEMENTPatent and Technology License and Purchase Option Agreement • March 31st, 2017 • Q BioMed Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 31st, 2017 Company Industry JurisdictionThis Patent and Technology License and Purchase Option Agreement is entered into on June 20, 2016 (“Signing Date”) by and between (i) Q BioMed Inc. (“Q Bio”) and (ii) Bio-Nucleonics Inc. (“BNI”): BNI and Q Bio are hereinafter also referred to individually as a “Party” and collectively as the “Parties.”
PATENT AND TECHNOLOGY LICENSE AND PURCHASE OPTION AGREEMENTPatent and Technology License and Purchase Option Agreement • March 11th, 2016 • Q BioMed Inc. • Services-computer programming services • New York
Contract Type FiledMarch 11th, 2016 Company Industry JurisdictionThis Patent and Technology License and Purchase Option Agreement is entered into on October [--], 2015 (“Signing Date”) by and between (i) Q BioMed Inc. (“Q Bio”) and (ii) Mannin Research Inc. (“Mannin”): Mannin and Q Bio are hereinafter also referred to individually as a “Party” and collectively as the “Parties.”
FIRST AMENDMENT TO PATENT AND TECHNOLOGY LICENSE AND PURCHASE OPTION AGREEMENTPatent and Technology License and Purchase Option Agreement • October 17th, 2016 • Q BioMed Inc. • Pharmaceutical preparations
Contract Type FiledOctober 17th, 2016 Company IndustryTHIS AGREEMENT (the “Amended Agreement”), dated September __, 2015, amends the Patent and Technology License and Purchase Option Agreement (the “License Agreement”) entered into on May 30, 2016 by and between (i) Q BioMed Inc. (“Q Bio”) and (ii) Bio-Nucleonics Inc. (“BNI”) (together, the “Parties”)